Topics
ovarian cancerDisease
To compare prognosis of advanced epithelial ovarian cancer (AEOC) patients based on where the first surgical assessment was performed
International audienceObjective: To compare survival and morbidity rates between primary cytoreducti...
The aim of this study was to compare the outcome of patients with advanced ovarian carcinoma treated...
Our study aims to evaluate the comparability of primary debulking surgery (PDS) and neoadjuvant chem...
To compare prognosis of advanced epithelial ovarian cancer (AEOC) patients based on where the first ...
Aim: To compare prognosis of advanced epithelial ovarian cancer (AEOC) patients based on where the f...
OBJECTIVES: To investigate the survival-related factors of patients with advanced stage ovarian canc...
OBJECTIVES: Complete surgery with no macroscopic residual disease (RD) at primary (PDS) or interval ...
In Denmark, the proportion of women with ovarian cancer treated with neoadjuvant chemotherapy (NACT)...
The objective of the study was to analyze in a large series of unresectable advanced ovarian cancer ...
Newly diagnosed high grade serous epithelial ovarian cancer (EOC) patients are treated with radical ...
International audienceOur study aims to evaluate the comparability of primary debulking surgery (PDS...
ObjectivesWe performed a patterns-of-care study to characterize the types of patients with epithelia...
The aim of this study was to evaluate the role of neoadjuvant chemotherapy (NACT) in advanced ovaria...
Approximately 70% of women with epithelial ovarian cancer (EOC) are diagnosed with advanced stage di...
OBJECTIVE:To assess whether neoadjuvant chemotherapy (NACT) is superior to primary debulking surgery...
International audienceObjective: To compare survival and morbidity rates between primary cytoreducti...
The aim of this study was to compare the outcome of patients with advanced ovarian carcinoma treated...
Our study aims to evaluate the comparability of primary debulking surgery (PDS) and neoadjuvant chem...
To compare prognosis of advanced epithelial ovarian cancer (AEOC) patients based on where the first ...
Aim: To compare prognosis of advanced epithelial ovarian cancer (AEOC) patients based on where the f...
OBJECTIVES: To investigate the survival-related factors of patients with advanced stage ovarian canc...
OBJECTIVES: Complete surgery with no macroscopic residual disease (RD) at primary (PDS) or interval ...
In Denmark, the proportion of women with ovarian cancer treated with neoadjuvant chemotherapy (NACT)...
The objective of the study was to analyze in a large series of unresectable advanced ovarian cancer ...
Newly diagnosed high grade serous epithelial ovarian cancer (EOC) patients are treated with radical ...
International audienceOur study aims to evaluate the comparability of primary debulking surgery (PDS...
ObjectivesWe performed a patterns-of-care study to characterize the types of patients with epithelia...
The aim of this study was to evaluate the role of neoadjuvant chemotherapy (NACT) in advanced ovaria...
Approximately 70% of women with epithelial ovarian cancer (EOC) are diagnosed with advanced stage di...
OBJECTIVE:To assess whether neoadjuvant chemotherapy (NACT) is superior to primary debulking surgery...
International audienceObjective: To compare survival and morbidity rates between primary cytoreducti...
The aim of this study was to compare the outcome of patients with advanced ovarian carcinoma treated...
Our study aims to evaluate the comparability of primary debulking surgery (PDS) and neoadjuvant chem...